
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Antengene Corporation Limited (Antengene, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative first-in-class/best-in-class therapeutics for the treatment of hematologic malignancies and solid tumors, in realizing its vision of Treating Patients Beyond Borders. Since 2017, Antengene has built a pipeline of 9 oncology programs at various stages going from clinical to commercial, including 6 with global rights, and 3 with rights for the APAC region. We have successfully obtained marketing authorizations for selinexor, Antengenes lead asset, in multiple Asia Pacific counties and regions including mainland China, Taiwan,China, South Korea,...
抗肿瘤创新药物,新药开发,and 临床研究
Antengene operates in the Pharmaceutical manufacturing industry.
Antengene's revenue is 11m - 100m
Antengene has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.